Search Results - "Meriggiola, M C"

Refine Results
  1. 1

    Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review by Asscheman, H., T'Sjoen, G., Lemaire, A., Mas, M., Meriggiola, M. C., Mueller, A., Kuhn, A., Dhejne, C., Morel-Journel, N., Gooren, L. J.

    Published in ANDROLOGIA (01-09-2014)
    “…Summary Administration of cross‐sex hormones to male‐to‐female transsexual subjects, usually oestrogens + often anti‐androgens, such as cyproterone acetate,…”
    Get full text
    Journal Article
  2. 2

    Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective by Meriggiola, M C, Jannini, E A, Lenzi, A, Maggi, M, Manieri, C

    Published in European journal of endocrinology (01-05-2010)
    “…The treatment of transsexual subjects is a challenging task for the endocrinologist who, in collaboration with the mental health professional and the surgeon,…”
    Get full text
    Journal Article
  3. 3

    Cervical length and risk of antepartum bleeding in women with complete placenta previa by Ghi, T., Contro, E., Martina, T., Piva, M., Morandi, R., Orsini, L. F., Meriggiola, M. C., Pilu, G., Morselli‐Labate, A. M., De Aloysio, D., Rizzo, N., Pelusi, G.

    Published in Ultrasound in obstetrics & gynecology (01-02-2009)
    “…Objective To evaluate if cervical length predicts prepartum bleeding and emergency Cesarean section in cases of placenta previa. Methods Between September 2005…”
    Get full text
    Journal Article
  4. 4

    Childhood maltreatment in subjects with male-to-female gender identity disorder by Bandini, E, Fisher, A D, Ricca, V, Ristori, J, Meriggiola, M C, Jannini, E A, Manieri, C, Corona, G, Monami, M, Fanni, E, Galleni, A, Forti, G, Mannucci, E, Maggi, M

    “…Childhood maltreatment (CM) is quite common and constitutes a nonspecific risk factor for a range of different psychiatric symptoms during lifespan. It has…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Testosterone Undecanoate Maintains Spermatogenic Suppression Induced by Cyproterone Acetate Plus Testosterone Undecanoate in Normal Men by Meriggiola, M. C., Costantino, A., Cerpolini, S., Bremner, W. J., Huebler, D., Morselli-Labate, A. M., Kirsch, B., Bertaccini, A., Pelusi, C., Pelusi, G.

    “…In this study we evaluated whether testosterone undecanoate (TU), alone or combined with low dose cyproterone acetate (CPA), can maintain spermatogenic…”
    Get full text
    Journal Article
  7. 7

    SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people by Fisher, A. D., Senofonte, G., Cocchetti, C., Guercio, G., Lingiardi, V., Meriggiola, M. C., Mosconi, M., Motta, G., Ristori, J., Speranza, A. M., Pierdominici, M., Maggi, M., Corona, G., Lombardo, F.

    Published in Journal of endocrinological investigation (01-03-2022)
    “…Purpose Gender Incongruence (GI) is a marked and persistent incongruence between an individual's experienced and the assigned gender at birth. In the recent…”
    Get full text
    Journal Article
  8. 8

    Three‐dimensional transvaginal sonography in local staging of cervical carcinoma: description of a novel technique and preliminary results by Ghi, T., Giunchi, S., Kuleva, M., Santini, D., Savelli, L., Formelli, G., Casadio, P., Costa, S., Meriggiola, M. C., Pelusi, G.

    Published in Ultrasound in obstetrics & gynecology (01-10-2007)
    “…Objective To evaluate the feasibility of three‐dimensional multiplanar sonography in the local staging of cervical carcinoma. Methods Between January 2005 and…”
    Get full text
    Journal Article
  9. 9

    A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive by MERIGGIOLA, M. C, BREMNER, W. J, PAULSEN, C. A, VALDISERRI, A, INCORVAIA, L, MOTTA, R, PAVANI, A, CAPELLI, M, FLAMIGNI, C

    “…In this study we tested the effectiveness of the combined administration of cyproterone acetate (CPA) and testosterone enanthate (TE) in suppressing…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Low dose of cyproterone acetate and testosterone enanthate for contraception in men by Meriggiola, M C, Bremner, W J, Costantino, A, Di Cintio, G, Flamigni, C

    Published in Human reproduction (Oxford) (01-05-1998)
    “…After a control phase, 10 normal men received cyproterone acetate (CPA) at a dose of 25 mg/day (CPA-25; n=5) or 12.5 mg/day (CPA-12.5; n=5) plus testosterone…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and -β expression of young women by Baldassarre, M, Giannone, F A, Foschini, M P, Battaglia, C, Busacchi, P, Venturoli, S, Meriggiola, M C

    “…To date, the effects of long-term testosterone (T) administration on the human vagina are not completely understood. Thus, the aim of this study was to…”
    Get full text
    Journal Article
  15. 15

    A placebo-controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effect on anthropometric, metabolic and biochemical parameters by Pelusi, C., Costantino, A., Cerpolini, S., Pelusi, G., Meriggiola, M. C., Pasquali, R.

    Published in International journal of andrology (01-12-2011)
    “…Summary Testosterone administered alone or in combination with progestogens in male contraception induces reversible oligo‐azoospermia, but its effects on body…”
    Get full text
    Journal Article
  16. 16

    Recent advances in hormonal male contraception by Meriggiola, M.C., Costantino, A., Cerpolini, S.

    Published in Contraception (01-04-2002)
    “…Hormones inhibit fertility in men by suppressing sperm production. Testosterone-enanthate induced azoospermia has proven to provide optimal contraceptive…”
    Get full text
    Book Review Journal Article
  17. 17

    Androgen receptor expression in the human vagina under different physiological and treatment conditions by Baldassarre, M, Perrone, A M, Giannone, F A, Armillotta, F, Battaglia, C, Costantino, A, Venturoli, S, Meriggiola, M C

    “…Recent data report an important role of testosterone (T) in modulating female sexual responses, but little is known about the expression and distribution of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men by Meriggiola, M C, Bremner, W J, Costantino, A, Pavani, A, Capelli, M, Flamigni, C

    Published in Fertility and sterility (01-11-1997)
    “…To test the effectiveness, safety, and reversibility of the combined administration of cyproterone acetate and T undecanoate. Open clinical trial. Healthy…”
    Get more information
    Journal Article
  20. 20

    Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men by Gambineri, A, Pagotto, U, De Lasio, R, Meriggiola, M C, Costantino, A, Patton, L, Pelusi, C, Pelusi, G, Pasquali, R

    Published in Journal of endocrinological investigation (01-03-2005)
    “…The aim of this study was to evaluate the effect of selective and short-term sex hormone modifications on ghrelin levels in normal-weight eugonadal men…”
    Get full text
    Journal Article